TSLP mRNA was overexpressed in cancer tissue. Tregs expressing TSLPR were increased in CRCs and were associated with progression of CRCs in human. A monoclonal antibody anti-TSLP reduced the size and number of CRC in mice. This evidence concerns the gene CRLF2 and cancer.